Breathe Better. Live Better.

• Respiratory diseases are associated with excess mortality, reducedquality of life for patients, and high health-care costs
• In 2019, approximately 8372 people with respiratory diseases died, compared to 6129 in 2010
• Respiratory diseases represented the 5th leading cause of death in Australia, according to the Australian Bureau of Statistics

According to the World Health Organisation (WHO), asthma and chronic obstructive pulmonary disease (COPD) are among the most common respiratory diseases affecting people worldwide

• AirPhysio is an International Award-winning mucus clearance and lung expansion medical device.
• AirPhysio uses an all natural process called Oscillating Positive Expiratory Pressure which is similar to the cough mechanism.
• AirPhysio is on the ARTG for Australia and CE for Europe for medical devices and has been validated by Griffith University.

AirPhysio is a drug-free handheld Oscillating Positive Expiratory Pressure (OPEP) device designed to assist in the clearance of secretions from the lungs and improving lung capacity by:

Vibrating the airways:
Which loosens the bond of mucus to the airway walls for mucus clearance

Intermittently increasing endobronchial pressure:
Which assists in maintaining the clearing of the airways while a person exhales so that mucus does not become trapped as it moves up the air canal

Accelerating expiratory airflow:
Which facilitates the upward movement of the mucus through the airways so that it can be more easily cleared.

• The use of AirPhysio after the use of beta2-agonist shows a significantly enhanced effect of bronchodilative effect in patients with an FEV1 below 85% FVC, over beta2-agonist therapy by itself.
• The additional effect of AirPhysio use in improving pulmonary function after beta2-agonist nebulization therapy is a result of an enhancement in mucus clearance.

Randomised, double blinded study to differentiate the effect of heliox and oxygen with and without positive expiratory pressure (PEP), on delivery of radiotagged inhaled bronchodilators on pulmonary function and deposition in 32 patients with moderate to severe asthma.

• In asthmatics, different degrees of airway obstruction cause heterogeneous drug deposition during nebulisation.
• Deposition is least in more affected areas, thereby compromising the benefits of aerosol therapy in these patients.

1. Take a deep breathe (abdominal breath) into your lungs and fill them completely.
2. Hold your breath for 2 to 3 seconds.
3. Place the AirPhysio device into your mouth and exhale through the device at a reasonably fast, but consistent pace for between 3-5 seconds until you empty your lungs. i.e. don’t try and blow too hard too quickly as this may cause you to over exert your lung muscles and leaving you feeling tight in the chest, so take it easy and don’t push too hard.
4. Most people can get it oscillating without too much exertion, but some people struggle to start with. But once your lungs are at optimal lung capacity, you should be able to lift the ball bearing slightly off the cone and have it oscillating.
5. Adjust the device to have the cap facing the ceiling and tilt it until you feel maximum vibrations within your chest, try to keep cheeks stiff to help amplify the affect in your chest.
6. After exhaling through the device, you may feel mucus accumulating near the top of your lungs or at the back of your throat, if so, initiate a cough to expel the mucus. If not, the mucus will continue working up to the throat and maybe swallowed as a normal process.
7. Repeat steps 1 through 6 for approx. 2 times per minute for up to 5 minutes, taking two deep breaths in between each session to reduce the chance of feeling lightheaded.

• An international award-winning mucus clearance and lung expansion medical device.
• Helps treat various respiratory complications.
• Removes mucus fromthe lungs while helping to maintain maximum
• lung capacity.
• Fewer cases of fever and reduced length of hospital stay in thoracic
• and upper abdominal postoperative adult patients.
• Significantly increases bronchodilators effect when used
• concomitantly.
• Self-administered and easy to use. Recommended by guidelines.